These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34629712)

  • 21. Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT).
    Helmberger T; Golfieri R; Pech M; Pfammatter T; Arnold D; Cianni R; Maleux G; Munneke G; Pellerin O; Peynircioglu B; Sangro B; Schaefer N; de Jong N; Bilbao JI; ;
    Cardiovasc Intervent Radiol; 2021 Jan; 44(1):21-35. PubMed ID: 32959085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in patients treated with transarterial radioembolization for unresectable and chemorefractory colorectal cancer with liver metastases.
    Jia Z; Paz-Fumagalli R; Frey GT; Sella DM; McKinney JM; Wang W
    Expert Rev Gastroenterol Hepatol; 2019 Sep; 13(9):899-905. PubMed ID: 31104533
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors.
    Kuei A; Saab S; Cho SK; Kee ST; Lee EW
    World J Gastroenterol; 2015 Jul; 21(27):8271-83. PubMed ID: 26217079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right- Versus Left-Sided Primary Tumor Location.
    Wu V; Li MD; Goodwin JS; Wehrenberg-Klee EP; Zurkiya O; Kalva SP; Ganguli S
    AJR Am J Roentgenol; 2021 Nov; 217(5):1141-1152. PubMed ID: 33594907
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatectomy, RFA, and Other Liver Directed Therapies for Treatment of Breast Cancer Liver Metastasis: A Systematic Review.
    Rivera K; Jeyarajah DR; Washington K
    Front Oncol; 2021; 11():643383. PubMed ID: 33842354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases.
    Gupta S
    Semin Intervent Radiol; 2013 Mar; 30(1):28-38. PubMed ID: 24436515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond hepatocellular carcinoma and colorectal metastasis: the expanding applications of radioembolization.
    Zurkiya O; Ganguli S
    Front Oncol; 2014; 4():150. PubMed ID: 24982850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma.
    Kirchner T; Marquardt S; Werncke T; Kirstein MM; Brunkhorst T; Wacker F; Vogel A; Rodt T
    Abdom Radiol (NY); 2019 Apr; 44(4):1554-1561. PubMed ID: 30311050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence-Based Integration of Yttrium-90 Radioembolization in the Contemporary Management of Hepatic Metastases from Colorectal Cancer.
    Wang DS; Louie JD; Sze DY
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):74-80. PubMed ID: 31079714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case Series.
    Zheng J; Irani Z; Lawrence D; Flaherty K; Arellano RS
    J Vasc Interv Radiol; 2018 Oct; 29(10):1369-1375. PubMed ID: 30174161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoembolization Versus Radioembolization for Neuroendocrine Liver Metastases: A Meta-analysis Comparing Clinical Outcomes.
    Ngo L; Elnahla A; Attia AS; Hussein M; Toraih EA; Kandil E; Killackey M
    Ann Surg Oncol; 2021 Apr; 28(4):1950-1958. PubMed ID: 33393019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term survival with transarterial chemoembolization and radioembolization in a patient with cancers of unknown primary.
    Aktas G; Kus T; Metin T; Kervancioglu S; Elboga U
    Onco Targets Ther; 2018; 11():1885-1889. PubMed ID: 29670363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional Therapies for Colorectal Liver Metastases: Systematic Review and Clinical Practice Guideline.
    Karanicolas P; Beecroft JR; Cosby R; David E; Kalyvas M; Kennedy E; Sapisochin G; Wong R; Zbuk K;
    Clin Colorectal Cancer; 2021 Mar; 20(1):20-28. PubMed ID: 33257278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yttrium-90 Radioembolization for Liver-Dominant Metastatic Prostate Cancer: A Case Series.
    Bibok A; Kis B; Frakes J; Hoffe S; Zhang J; Jain R; Parikh N
    J Vasc Interv Radiol; 2022 Sep; 33(9):1061-1065. PubMed ID: 36049841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Performance of Theranostic Radionuclides Used in Transarterial Radioembolization for Liver Cancer.
    Li R; Li D; Jia G; Li X; Sun G; Zuo C
    Front Oncol; 2020; 10():551622. PubMed ID: 33569342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of failed therapy evaluations in radioembolization of primary and secondary liver cancers.
    Masthoff M; Schindler P; Harders F; Heindel W; Wilms C; Schmidt HH; Pascher A; Stegger L; Rahbar K; Köhler M; Wildgruber M
    J Cancer Res Clin Oncol; 2021 May; 147(5):1537-1545. PubMed ID: 33156407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SIR-Spheres yttrium-90 radioembolization for the treatment of unresectable liver cancers.
    Golfieri R
    Hepat Oncol; 2014 Jun; 1(3):265-283. PubMed ID: 30190962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection.
    She WH; Cheung TT; Yau TC; Chan AC; Chok KS; Chu FS; Liu RK; Poon RT; Chan SC; Fan ST; Lo CM
    Hepatobiliary Surg Nutr; 2014 Aug; 3(4):185-93. PubMed ID: 25202695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study.
    Barakat E; Bibok A; Rishi A; Ahmed A; Frakes JM; Hoffe SE; Armaghani AJ; Soyano AE; Costa RLB; El-Haddad G; Choi J; Kis B
    Adv Radiat Oncol; 2022; 7(1):100838. PubMed ID: 35071835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.